Qualitative Differences Between the IFNα subtypes and IFNβ Influence Chronic Mucosal HIV-1 Pathogenesis.

The Type I Interferons (IFN-Is) are innate antiviral cytokines that include 12 different IFNα subtypes and IFNβ that signal through the IFN-I receptor (IFNAR), inducing hundreds of IFN-stimulated genes (ISGs) that comprise the 'interferome'. Quantitative differences in IFNAR binding correl...

Full description

Bibliographic Details
Main Authors: Kejun Guo, Guannan Shen, Jon Kibbie, Tania Gonzalez, Stephanie M Dillon, Harry A Smith, Emily H Cooper, Kerry Lavender, Kim J Hasenkrug, Kathrin Sutter, Ulf Dittmer, Miranda Kroehl, Katerina Kechris, Cara C Wilson, Mario L Santiago
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2020-10-01
Series:PLoS Pathogens
Online Access:https://doi.org/10.1371/journal.ppat.1008986
id doaj-3fba1411c8544aef9e0108a9c016d94d
record_format Article
spelling doaj-3fba1411c8544aef9e0108a9c016d94d2021-04-21T17:52:23ZengPublic Library of Science (PLoS)PLoS Pathogens1553-73661553-73742020-10-011610e100898610.1371/journal.ppat.1008986Qualitative Differences Between the IFNα subtypes and IFNβ Influence Chronic Mucosal HIV-1 Pathogenesis.Kejun GuoGuannan ShenJon KibbieTania GonzalezStephanie M DillonHarry A SmithEmily H CooperKerry LavenderKim J HasenkrugKathrin SutterUlf DittmerMiranda KroehlKaterina KechrisCara C WilsonMario L SantiagoThe Type I Interferons (IFN-Is) are innate antiviral cytokines that include 12 different IFNα subtypes and IFNβ that signal through the IFN-I receptor (IFNAR), inducing hundreds of IFN-stimulated genes (ISGs) that comprise the 'interferome'. Quantitative differences in IFNAR binding correlate with antiviral activity, but whether IFN-Is exhibit qualitative differences remains controversial. Moreover, the IFN-I response is protective during acute HIV-1 infection, but likely pathogenic during the chronic stages. To gain a deeper understanding of the IFN-I response, we compared the interferomes of IFNα subtypes dominantly-expressed in HIV-1-exposed plasmacytoid dendritic cells (1, 2, 5, 8 and 14) and IFNβ in the earliest cellular targets of HIV-1 infection. Primary gut CD4 T cells from 3 donors were treated for 18 hours ex vivo with individual IFN-Is normalized for IFNAR signaling strength. Of 1,969 IFN-regulated genes, 246 'core ISGs' were induced by all IFN-Is tested. However, many IFN-regulated genes were not shared between the IFNα subtypes despite similar induction of canonical antiviral ISGs such as ISG15, RSAD2 and MX1, formally demonstrating qualitative differences between the IFNα subtypes. Notably, IFNβ induced a broader interferome than the individual IFNα subtypes. Since IFNβ, and not IFNα, is upregulated during chronic HIV-1 infection in the gut, we compared core ISGs and IFNβ-specific ISGs from colon pinch biopsies of HIV-1-uninfected (n = 13) versus age- and gender-matched, antiretroviral-therapy naïve persons with HIV-1 (PWH; n = 19). Core ISGs linked to inflammation, T cell activation and immune exhaustion were elevated in PWH, positively correlated with plasma lipopolysaccharide (LPS) levels and gut IFNβ levels, and negatively correlated with gut CD4 T cell frequencies. In sharp contrast, IFNβ-specific ISGs linked to protein translation and anti-inflammatory responses were significantly downregulated in PWH, negatively correlated with gut IFNβ and LPS, and positively correlated with plasma IL6 and gut CD4 T cell frequencies. Our findings reveal qualitative differences in interferome induction by diverse IFN-Is and suggest potential mechanisms for how IFNβ may drive HIV-1 pathogenesis in the gut.https://doi.org/10.1371/journal.ppat.1008986
collection DOAJ
language English
format Article
sources DOAJ
author Kejun Guo
Guannan Shen
Jon Kibbie
Tania Gonzalez
Stephanie M Dillon
Harry A Smith
Emily H Cooper
Kerry Lavender
Kim J Hasenkrug
Kathrin Sutter
Ulf Dittmer
Miranda Kroehl
Katerina Kechris
Cara C Wilson
Mario L Santiago
spellingShingle Kejun Guo
Guannan Shen
Jon Kibbie
Tania Gonzalez
Stephanie M Dillon
Harry A Smith
Emily H Cooper
Kerry Lavender
Kim J Hasenkrug
Kathrin Sutter
Ulf Dittmer
Miranda Kroehl
Katerina Kechris
Cara C Wilson
Mario L Santiago
Qualitative Differences Between the IFNα subtypes and IFNβ Influence Chronic Mucosal HIV-1 Pathogenesis.
PLoS Pathogens
author_facet Kejun Guo
Guannan Shen
Jon Kibbie
Tania Gonzalez
Stephanie M Dillon
Harry A Smith
Emily H Cooper
Kerry Lavender
Kim J Hasenkrug
Kathrin Sutter
Ulf Dittmer
Miranda Kroehl
Katerina Kechris
Cara C Wilson
Mario L Santiago
author_sort Kejun Guo
title Qualitative Differences Between the IFNα subtypes and IFNβ Influence Chronic Mucosal HIV-1 Pathogenesis.
title_short Qualitative Differences Between the IFNα subtypes and IFNβ Influence Chronic Mucosal HIV-1 Pathogenesis.
title_full Qualitative Differences Between the IFNα subtypes and IFNβ Influence Chronic Mucosal HIV-1 Pathogenesis.
title_fullStr Qualitative Differences Between the IFNα subtypes and IFNβ Influence Chronic Mucosal HIV-1 Pathogenesis.
title_full_unstemmed Qualitative Differences Between the IFNα subtypes and IFNβ Influence Chronic Mucosal HIV-1 Pathogenesis.
title_sort qualitative differences between the ifnα subtypes and ifnβ influence chronic mucosal hiv-1 pathogenesis.
publisher Public Library of Science (PLoS)
series PLoS Pathogens
issn 1553-7366
1553-7374
publishDate 2020-10-01
description The Type I Interferons (IFN-Is) are innate antiviral cytokines that include 12 different IFNα subtypes and IFNβ that signal through the IFN-I receptor (IFNAR), inducing hundreds of IFN-stimulated genes (ISGs) that comprise the 'interferome'. Quantitative differences in IFNAR binding correlate with antiviral activity, but whether IFN-Is exhibit qualitative differences remains controversial. Moreover, the IFN-I response is protective during acute HIV-1 infection, but likely pathogenic during the chronic stages. To gain a deeper understanding of the IFN-I response, we compared the interferomes of IFNα subtypes dominantly-expressed in HIV-1-exposed plasmacytoid dendritic cells (1, 2, 5, 8 and 14) and IFNβ in the earliest cellular targets of HIV-1 infection. Primary gut CD4 T cells from 3 donors were treated for 18 hours ex vivo with individual IFN-Is normalized for IFNAR signaling strength. Of 1,969 IFN-regulated genes, 246 'core ISGs' were induced by all IFN-Is tested. However, many IFN-regulated genes were not shared between the IFNα subtypes despite similar induction of canonical antiviral ISGs such as ISG15, RSAD2 and MX1, formally demonstrating qualitative differences between the IFNα subtypes. Notably, IFNβ induced a broader interferome than the individual IFNα subtypes. Since IFNβ, and not IFNα, is upregulated during chronic HIV-1 infection in the gut, we compared core ISGs and IFNβ-specific ISGs from colon pinch biopsies of HIV-1-uninfected (n = 13) versus age- and gender-matched, antiretroviral-therapy naïve persons with HIV-1 (PWH; n = 19). Core ISGs linked to inflammation, T cell activation and immune exhaustion were elevated in PWH, positively correlated with plasma lipopolysaccharide (LPS) levels and gut IFNβ levels, and negatively correlated with gut CD4 T cell frequencies. In sharp contrast, IFNβ-specific ISGs linked to protein translation and anti-inflammatory responses were significantly downregulated in PWH, negatively correlated with gut IFNβ and LPS, and positively correlated with plasma IL6 and gut CD4 T cell frequencies. Our findings reveal qualitative differences in interferome induction by diverse IFN-Is and suggest potential mechanisms for how IFNβ may drive HIV-1 pathogenesis in the gut.
url https://doi.org/10.1371/journal.ppat.1008986
work_keys_str_mv AT kejunguo qualitativedifferencesbetweentheifnasubtypesandifnbinfluencechronicmucosalhiv1pathogenesis
AT guannanshen qualitativedifferencesbetweentheifnasubtypesandifnbinfluencechronicmucosalhiv1pathogenesis
AT jonkibbie qualitativedifferencesbetweentheifnasubtypesandifnbinfluencechronicmucosalhiv1pathogenesis
AT taniagonzalez qualitativedifferencesbetweentheifnasubtypesandifnbinfluencechronicmucosalhiv1pathogenesis
AT stephaniemdillon qualitativedifferencesbetweentheifnasubtypesandifnbinfluencechronicmucosalhiv1pathogenesis
AT harryasmith qualitativedifferencesbetweentheifnasubtypesandifnbinfluencechronicmucosalhiv1pathogenesis
AT emilyhcooper qualitativedifferencesbetweentheifnasubtypesandifnbinfluencechronicmucosalhiv1pathogenesis
AT kerrylavender qualitativedifferencesbetweentheifnasubtypesandifnbinfluencechronicmucosalhiv1pathogenesis
AT kimjhasenkrug qualitativedifferencesbetweentheifnasubtypesandifnbinfluencechronicmucosalhiv1pathogenesis
AT kathrinsutter qualitativedifferencesbetweentheifnasubtypesandifnbinfluencechronicmucosalhiv1pathogenesis
AT ulfdittmer qualitativedifferencesbetweentheifnasubtypesandifnbinfluencechronicmucosalhiv1pathogenesis
AT mirandakroehl qualitativedifferencesbetweentheifnasubtypesandifnbinfluencechronicmucosalhiv1pathogenesis
AT katerinakechris qualitativedifferencesbetweentheifnasubtypesandifnbinfluencechronicmucosalhiv1pathogenesis
AT caracwilson qualitativedifferencesbetweentheifnasubtypesandifnbinfluencechronicmucosalhiv1pathogenesis
AT mariolsantiago qualitativedifferencesbetweentheifnasubtypesandifnbinfluencechronicmucosalhiv1pathogenesis
_version_ 1714665569712603136